Today's Date
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
(
RAVE
)
ITN Protocol #:
ITN021AI
Branded Name:
RAVE
ClinicalTrials.Gov ID:
NCT00104299Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis
Clinical Operations Manager
ITN Biostat
ITN Clinical Trial Physician
Rho Data Manager
Rho Scientist
PPD Lead Monitor
Study Personnel:
